Search research articles
Contact Us
Filters
Showing results (61-70 of 96) with videos related to
Page
of 10
Sort By:
Cancer Immunology, Immunotherapy : CII
|
January 1, 1989
Interferon-gamma (IFN-gamma) and interleukin-2 in the generation of lymphokine-activated killer cell cytotoxicity--IFN-gamma-induced suppressive activity
M Toledano, C Mathiot, J Michon, et al.
Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis
|
May 1, 1997
Extracorporeal photochemotherapy: a treatment for organ graft rejection
F Heshmati, R Tavakoli, A Michel, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|
October 3, 2002
[The quality concept. The French Graft Establishment]
Ch Giraud, J M Korach, G Andreu, et al.
Nouvelle Revue Francaise D'Hematologie
|
January 1, 1986
[Expansion of erythropoiesis and granulopoiesis after bone marrow grafts]
B Rio, M Cadiou, G Andreu, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|
September 25, 2012
[Transfusion serious adverse events and root cause analysis]
É Falzone, Y Auroy, C Hoffmann, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|
June 12, 2003
[Application of molecular biology to blood transfusion safety: the nucleic acid testing]
A Assal, J Coste, V Barlet, et al.
Journal of Interferon Research
|
January 1, 1984
Studies on purification of human gamma interferon: chromatographic behavior of accompanying IL2 and B-cell helper activity
J Wietzerbin, J P Kolb, A Senik, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|
October 30, 2012
[Errors of red cell concentrates recipients: method of analysis using the adverse events notified to the hemovigilance network in 2009]
E Falzone, Y Auroy, C Hoffmann, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|
January 1, 1996
[Viral attenuation of labile blood products]
G Folléa, P Hervé, G Andreu, et al.
Blood
|
July 1, 1989
Life-threatening intracranial bleeding associated with the presence of an antifactor VII autoantibody
A Delmer, M H Horellou, G Andreu, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 96) with videos related to
Sort By:
Page
of 10
Cancer Immunology, Immunotherapy : CII
|
January 1, 1989
Interferon-gamma (IFN-gamma) and interleukin-2 in the generation of lymphokine-activated killer cell cytotoxicity--IFN-gamma-induced suppressive activity
M Toledano, C Mathiot, J Michon, et al.
Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis
|
May 1, 1997
Extracorporeal photochemotherapy: a treatment for organ graft rejection
F Heshmati, R Tavakoli, A Michel, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|
October 3, 2002
[The quality concept. The French Graft Establishment]
Ch Giraud, J M Korach, G Andreu, et al.
Nouvelle Revue Francaise D'Hematologie
|
January 1, 1986
[Expansion of erythropoiesis and granulopoiesis after bone marrow grafts]
B Rio, M Cadiou, G Andreu, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|
September 25, 2012
[Transfusion serious adverse events and root cause analysis]
É Falzone, Y Auroy, C Hoffmann, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|
June 12, 2003
[Application of molecular biology to blood transfusion safety: the nucleic acid testing]
A Assal, J Coste, V Barlet, et al.
Journal of Interferon Research
|
January 1, 1984
Studies on purification of human gamma interferon: chromatographic behavior of accompanying IL2 and B-cell helper activity
J Wietzerbin, J P Kolb, A Senik, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|
October 30, 2012
[Errors of red cell concentrates recipients: method of analysis using the adverse events notified to the hemovigilance network in 2009]
E Falzone, Y Auroy, C Hoffmann, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|
January 1, 1996
[Viral attenuation of labile blood products]
G Folléa, P Hervé, G Andreu, et al.
Blood
|
July 1, 1989
Life-threatening intracranial bleeding associated with the presence of an antifactor VII autoantibody
A Delmer, M H Horellou, G Andreu, et al.
Page
of 10